Researchers seek to recruit 3,500 children and adults in the Pacific Northwest to assess how well vaccines protect against COVID-19.
With COVID rates rising, along with RSV and the flu, health officials are again urging caution. Infectious-diseases specialists offer tips.
Nanoparticle technology created by researchers at the University of Washington School of Medicine is featured in a vaccine for respiratory syncytial virus (commonly known as RSV).
